StonvexLoading…
StonvexStonvexStonvexCore line items from EMPD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $225.70K | $974.98K | $1.64M | $1.44M |
Operating Income | $-83.31M | $-153.48M | $-40.86M | $-6.38M |
Net Income | $-85.40M | $-150.05M | $-35.53M | $-6.36M |
EPS (Diluted) | $-2.59 | $-8.12 | $-2.85 | $-14.88 |
Total Assets | $217.82M | $372.44M | $492.26M | $17.94M |
Total Liabilities | $51.74M | $103.22M | $54.62M | $4.12M |
Cash & Equivalents | $5.70M | $8.96M | $18.82M | $11.79M |
Free Cash Flow OCF − CapEx | $-3.52M | $-18.05M | $-15.06M | $-7.44M |
Shares Outstanding | 29.33M | 33.80M | 42.34M | 533.01K |